Cargando…
NLRC5 potentiates anti-tumor CD8(+) T cells responses by activating interferon-β in endometrial cancer
OBJECTIVES: NLR family CARD domain containing 5 (NLRC5) could promote major histocompatibility complex class I (MHC-I)-dependent CD8(+) T cell-mediated anticancer immunity. In this study, the immunosurveillance role and underlying mechanisms of NLRC5 in endometrial cancer (EC) were characterized. ME...
Autores principales: | Zhang, Jing, Guo, Bao, Chen, Jia-Hua, Liu, Xiao-Jing, Zhang, Jun-Hui, Zhu, Hai-Qing, Wang, Wen-Yan, Tang, Zhen-Hai, Wei, Bing, Cao, Yun-Xia, Zhan, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407819/ https://www.ncbi.nlm.nih.gov/pubmed/37531863 http://dx.doi.org/10.1016/j.tranon.2023.101742 |
Ejemplares similares
-
METTL3 facilitates immunosurveillance by inhibiting YTHDF2-mediated NLRC5 mRNA degradation in endometrial cancer
por: Zhan, Lei, et al.
Publicado: (2023) -
NLRC5 Might Promote Endometrial Cancer Progression by Inducing PD-L1
Expression
por: Zhu, Su-ding, et al.
Publicado: (2022) -
NLRC5 promotes cell migration and invasion by activating the PI3K/AKT signaling pathway in endometrial cancer
por: Fan, Yijun, et al.
Publicado: (2020) -
NLRC5 Inhibits Inflammation of Secretory Phase Ectopic Endometrial Stromal Cells by Up-Regulating Autophagy in Ovarian Endometriosis
por: He, Runhua, et al.
Publicado: (2020) -
Transcription and splicing regulation by NLRC5 shape the interferon response in human pancreatic β cells
por: Szymczak, Florian, et al.
Publicado: (2022)